Immediate Impact
1 by Nobel laureates 9 from Science/Nature 58 standout
Citing Papers
Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC
2021 Standout
Pan-cancer single-cell landscape of tumor-infiltrating T cells
2021 StandoutScience
Works of G. Shankar being referenced
1265P IMpower150: A post hoc analysis of efficacy outcomes in patients with KRAS, STK11 and KEAP1 mutations
2020
Tumor mutation load assessed by FoundationOne (FM1) is associated with improved efficacy of atezolizumab (atezo) in patients with advanced NSCLC
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| G. Shankar | 133 | 76 | 76 | 138 | 21 | 367 | |
| Suqin Zheng | 85 | 125 | 35 | 100 | 13 | 385 | |
| Jianxiao Chen | 27 | 35 | 6 | 107 | 15 | 348 | |
| Huikai Zhang | 42 | 50 | 64 | 99 | 23 | 356 | |
| P. Pierre | 22 | 37 | 55 | 49 | 19 | 313 | |
| Zhongxu Zhu | 40 | 48 | 11 | 164 | 23 | 324 | |
| Biao Kuang | 25 | 12 | 6 | 143 | 20 | 355 | |
| Young Goo Kim | 34 | 15 | 68 | 107 | 27 | 375 | |
| Xiaoqiang Dong | 97 | 36 | 11 | 179 | 24 | 316 | |
| Sen Wei | 173 | 200 | 7 | 131 | 37 | 407 | |
| Elisa Martella | 44 | 47 | 105 | 23 | 403 |
All Works
Login with ORCID to disown or claim papers
Loading papers...